The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of non-receipt of first-line CDK 4/6 inhibitors (CDK4/6i) among patients with metastatic breast cancer (MBC).
 
Kimberley T Lee
Research Funding - Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly
 
Elaine Chiao
No Relationships to Disclose
 
David Lim
No Relationships to Disclose
 
Morgane Mouslim
No Relationships to Disclose
 
Chenguang Wang
Consulting or Advisory Role - Brillient; Saphire
 
Neha Mangini
No Relationships to Disclose
 
Vered Stearns
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Other Relationship - Immunomedics
 
Karen L. Smith
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I)
Honoraria - ASiM CME
Research Funding - Pfizer (Inst); Pfizer (Inst)